Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis

Zhang LiJun; Jia XiaoFang; Wu DaGe; Liu XiaoQian; Huang Yan; Zhang JiaoLi; Cheng NengNeng

doi:10.3969/j.issn.1001-5256.2014.10.020

Issue 10

Oct. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(10): 1053-1059

PDF( 1928 KB)

Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis

DOI: 10.3969/j.issn.1001-5256.2014.10.020

Shanghai Public Health Clinical Center affiliated to Fudan University

Research funding:

Received Date: 2014-01-03
Published Date: 2014-10-20

Abstract

Abstract

Objective The development of alcoholic liver fibrosis ( ALF) is a complex process involving both parenchymal and nonparenchymal cells. The knowledge about the proteome of liver nonparenchymal cells ( NPCs) in response to ethanol is limited. This paper aims to investigate the regulatory effect of alcohol on the protein expression in liver NPCs during liver fibrosis development and to provide new clues for understanding the molecular mechanism of liver fibrosis. Methods Rats were treated with ethanol by gastric administration to establish a liver fibrosis model. The pathological changes in the liver were evaluated by James staining. Liver NPCs were enriched by Percoll density gradient centrifugation, and proteins were extracted from NPCs by two-dimensional gel electrophoresis ( 2DE) and stained by Coomassie Brilliant Blue G-250. The differentially expressed proteins were identified by liquid chromatography-tandem mass spectrometry ( LC-MS / MS) . Some of the differentially expressed proteins were verified by real time RT-PCR and Western blot. The protein spots on 2DE gels were analyzed by two sample t-test. The RT-PCR results were statistically analyzed by Mann-Whitney test. Results A rat model of ALF was established. Among the NPCs purified by Percoll density gradient centrifugation, lymphocytes, Kupffer cells, and endothelial cells were enriched for 1. 5, 3. 2, and 3. 7 times, respectively. More than 800 protein spots were detected by 2DE, and there were 26 proteins with more than 2-fold increases or decreases in expression; 21 non-redundant proteins were identified by LC-MS /MS and real-time RT-PCR analysis of 7 of these proteins showed that the mRNA levels of ANXA3, CES3, ATPA and NDUFV2 were in accordance with the proteome analysis results. Conclusion This study detected and identified a group of differentially expressed proteins related to ALF. Our work might offer some new clues to understand the mechanism of ALF.
- liver cirrhosis, alcoholic,
- proteome

FullText(HTML)

References(20)

References

[1]ZHANG L, JIA X, FENG Y, et al.Plasma membrane proteome analysis of the early effect of alcohol on liver:implications for alcoholic liver disease[J].Acta Biochim Biophys Sin (Shanghai) , 2011, 43 (1) :19-29.

[2]JIA X, YIN L, FENG Y, et al.A dynamic plasma membrane proteome analysis of alcohol-induced liver cirrhosis[J].Proteome Sci, 2012, 2012, 10 (1) :39.

[3]AROOR AR, LOWERY RJ, RESTREPO RJ, et al.A Proteomic analysis of liver after ethanol binge in chronically ethanol treated rats[J].Proteome Sci, 2012, 10 (1) :29.

[4]COHEN JI, NAGY LE.Pathogenesis of alcoholic liver disease:interactions between parenchymal and non-parenchymal cells[J].J Dig Dis, 2011, 12 (1) :3-9.

[5]ZHANG LJ, WANG XE, PENG X, et al.Proteomic analysis of low-abundant integral plasma membrane proteins based on gels[J].Cell Mol Life Sci, 2006, 63 (15) :1790-1804.

[6]FRIEDMAN SL.Evolving challenges in hepatic fibrosis[J].Nat Rev Gastroenterol Hepatol, 2010, 7 (8) :425-436.

[7]YE LH, WANG CK, YANG L, et al.Effects of Ruangan Huajian granule on hepatic expression ofα-SMA, TGFβ1, and COL-Ⅰin C57 mice with experimental hepatic fibrosis[J].J Clin Hepatol, 2012, 28 (9) :685-688. (in Chinese) 叶立红, 王翀奎, 杨莉, 等.软肝化坚颗粒对肝纤维化模型C57小鼠肝组织α-SMA、TGFβ1表达和I型胶原水平的影响[J].临床肝胆病杂志, 2012, 28 (9) :685-688.

[8]FRIEDMAN SL.Hepatic stellate cells:protean, multifunctional, and enigmatic cells of the liver[J].Physiol Rev, 2008, 88 (1) :125-172.

[9]LEWIS W, DALAKAS MC.Mitochondrial toxicity of antiviral drugs[J].Nat Med, 1995, 1 (5) :417-422.

[10]PARZEFALL W, KAINZBAUER E, QIN HM, et al.Response of isolated hepatocytes from carcinogen sensitive (C3H) and insensitive (C57BL) mice to signals inducing replication or apoptosis[J].Arch Toxicol, 2002, 76 (12) :699-706.

[11]ZHANG LJ, JIA XF, TENG ZL, et al.Biomarkers of liver cancer related to hepatitis B virus selected by proteomics[J].J Clin Hepatol, 2011, 27 (5) :553-557. (in Chinese) 张丽军, 贾小芳, 滕珍林, 等.基于蛋白质组学筛选获得的乙型肝炎病毒相关肝癌诊断标志物的研究进展[J].临床肝胆病杂志, 2011, 27 (5) :553-557.

[12]ZHANG L, JIA X, ZHANG X, et al.Alpha-1 antitrypsin variants in plasma from HIV-infected patients revealed by proteomic and glycoproteomic analysis[J].Electrophoresis, 2010, 31 (20) :3437-3445.

[13]ZHANG L, JIA X, ZHANG X, et al.Proteomic analysis of PBMCs:characterization of potential HIV-associated proteins[J].Proteome Sci, 2010, 8:12.

[14]ZHANG L, PENG X, ZHANG Z, et al.Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis[J].J Cell Biochem, 2010, 110 (1) :219-228.

[15]ZHAO Q, FENG Y, JIA X, et al.Proteome analysis of hepatic non-parenchymal cells of immune liver fibrosis rats[J].Sci China Life Sci, 2014, 57 (3) :303-314.

[16]MOLLEKEN C, SITEK B, HENKEL C, et al.Detection of novel biomarkers of liver cirrhosis by proteomic analysis[J].Hepatology, 2009, 49 (4) :1257-1266.

[17]CHEUNG KJ, TILLEMAN K, DEFORCE D, et al.Proteomics in liver fibrosis is more than meets the eye[J].Eur J Gastroenterol Hepatol, 2008, 20 (5) :450-464.

[18]GALLIGAN JJ, SMATHERS RL, Shearn CT, et al.Oxidative stress and the ER stress response in a murine model for earlystage alcoholic liver disease[J].J Toxicol, 2012, 2012:207594.

[19]WEBB C, TWEDT D.Oxidative stress and liver disease[J].Vet Clin North Am Small Anim Pract, 2008, 38 (1) :125-135.

[20]ZHU R, WANG Y, ZHANG L, et al.Oxidative stress and liver disease[J].Hepatol Res, 2008, 42 (8) :741-749.

Relative Articles

[1]	Jinqiu YANG, Wenxia ZHAO, Cheng ZHOU, Tong LIU. Risk factors for the development of advanced liver fibrosis in nonalcoholic fatty liver disease and establishment of a nomogram model[J]. Journal of Clinical Hepatology, 2024, 40(8): 1579-1584. doi: 10.12449/JCH240812
[2]	Jing KUANG, Shuangqin TENG, Tongtong SHEN, Yiran YAN, Wei WANG, Chuan SHEN, Caiyan ZHAO. Risk factors for portopulmonary hypertension in liver cirrhosis and construction of a predictive model[J]. Journal of Clinical Hepatology, 2024, 40(9): 1802-1806. doi: 10.12449/JCH240914
[3]	Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119
[4]	Mingqiang ZHU, Dashuai YANG, Junpeng PEI, Xiangyun XIONG, Yang SU, Youming DING. Analysis of influencing factors on biliary complications after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2023, 39(7): 1627-1632. doi: 10.3969/j.issn.1001-5256.2023.07.017
[5]	Sufang LU, Rui HUANG, Hongli ZHAO, Dandan WANG, Yuzhen DING, Hong ZHOU. Value of a risk assessment model in predicting venous thromboembolism in patients with liver failure after artificial liver support therapy[J]. Journal of Clinical Hepatology, 2023, 39(3): 613-619. doi: 10.3969/j.issn.1001-5256.2023.03.019
[6]	Bingbing ZHU, Jinxiang YANG, Qun ZHANG, Fangyuan GAO, Xianbo WANG. Risk factors for the 90-day prognosis of patients with type I hepatorenal syndrome and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2022, 38(7): 1561-1565. doi: 10.3969/j.issn.1001-5256.2022.07.019
[7]	Perioperative Management Group, Chinese Society of Organ Transplantation, Chinese Medical Association. Expert consensus on perioperative vascular complications for liver transplantation(2021)[J]. Journal of Clinical Hepatology, 2021, 37(9): 2054-2057. doi: 10.3969/j.issn.1001-5256.2021.09.010
[8]	Bing GUO, Mingquan PANG, Xiaolei XU, Junwei HAN, Haijiu WANG. Establishment and evaluation of a nomogram for predicting post-hepatectomy complications in two types of hepatic echinococcosis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2626-2631. doi: 10.3969/j.issn.1001-5256.2021.11.027
[9]	Yun ZHAO, Lijin ZHAO. Research advances in the risk factors for infection after liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(8): 1957-1962. doi: 10.3969/j.issn.1001-5256.2021.08.046
[10]	Mingwei LI, Jian GAO, Xiangwei ZHAI, Xiangjun QIAN, Xiajie WEN, Mingjie YAO, Zhaojun DUAN, Erjiang ZHAO, Ling ZHANG, Fengmin LU. Construction and analysis of a predictive model for posthepatectomy recurrence in patients with hepatocellular carcinoma based on preoperative CXCL13 measurement[J]. Journal of Clinical Hepatology, 2021, 37(4): 823-828. doi: 10.3969/j.issn.1001-5256.2021.04.020
[11]	Wang Han, Zuo XiangRong, Cao Quan. Predictive factors and interventions for prolonged mechanical ventilation after liver transplantation[J]. Journal of Clinical Hepatology, 2020, 36(7): 1658-1662. doi: 10.3969/j.issn.1001-5256.2020.07.047
[12]	Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015
[13]	Zheng WeiPing, Shen ZhongYang. Risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma and related control strategies[J]. Journal of Clinical Hepatology, 2019, 35(11): 2391-2395. doi: 10.3969/j.issn.1001-5256.2019.11.003
[14]	Chen Long, Li Yue. The risk factors and prediction systems for posthepatectomy complications[J]. Journal of Clinical Hepatology, 2019, 35(1): 217-221. doi: 10.3969/j.issn.1001-5256.2019.01.048
[15]	Jie EnBo, Xuan FengHui, Sun XiaoDong, Sun DaWei, Lu: GuoYue. An analysis of risk factors for early complications after liver transplantation[J]. Journal of Clinical Hepatology, 2018, 34(6): 1282-1288. doi: 10.3969/j.issn.1001-5256.2018.06.030
[16]	Zhang YinTao, Meng JinYing, Guo ChunGuang, Wang Hua. Risk factors for biliary complications after common bile duct exploration combined with primary suture[J]. Journal of Clinical Hepatology, 2017, 33(2): 304-307. doi: 10.3969/j.issn.1001-5256.2017.02.021
[17]	Wang XinWei, Zhao ZongGang. Risk factors for infectious complications after hepatectomy in patients with intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(9): 1754-1757. doi: 10.3969/j.issn.1001-5256.2017.09.025
[18]	Wang MingYue, Lu ZhiYan. Imaging evaluation of complications after liver transplantation[J]. Journal of Clinical Hepatology, 2016, 32(12): 2295-2299. doi: 10.3969/j.issn.1001-5256.2016.12.013
[19]	Lu: GuoYue. Risk factors for biliary complications after liver transplantation from donation after cardiac death[J]. Journal of Clinical Hepatology, 2015, 31(12): 2027-2030. doi: 10.3969/j.issn.1001-5256.2015.12.009
[20]	Chen Man, Zhang Xia. Research advances in molecular prediction of recurrence and metastasis of primary liver cancer after liver transplantation[J]. Journal of Clinical Hepatology, 2014, 30(12): 1361-1365. doi: 10.3969/j.issn.1001-5256.2014.12.032

Supplements(0)

Cited By

Cited by

Periodical cited type(4)

1.	李正优，李荷，周俊. 预见性护理结合舒适护理干预在肝移植术后患者中的应用. 西藏医药. 2024(06): 123-125 .
2.	李珊珊，王媛，高春辉. 早期下床活动对肝移植术后患者胃肠功能及下肢血流的影响. 国际移植与血液净化杂志. 2023(01): 41-44 .
3.	张欣悦，王海刚，王昊，杨传伟. 他克莫司治疗1例肝移植术后患者的药学监护. 中国医药导报. 2023(14): 183-187 .
4.	种庚，彭晓春，吴若林，赵红川，邵敏. 成人肝移植术后早期严重并发症相关危险因素分析. 肝胆外科杂志. 2022(06): 454-459 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2593) PDF downloads(522)

Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis

DOI: 10.3969/j.issn.1001-5256.2014.10.020